🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Pre-clinical Models of Large Vessel Occlusion Stroke. SHAHID NIMJEE Amon Zakeri As candidate drugs transition from small- to large-animal preclinical testing, it's crucial to account for anatomic variations in architecture and size among animals. ahajournals.org/doi/full/10.11…

Come one, come all!! Stellar group of panelists for our next StrokeNet RCC Journal Club! Eva A. Mistry, MBBS, MSCI, FAHA natalie kreitzer SHAHID NIMJEE Stacie UC Health UofL Health The Ohio State University College of Medicine

Basking Biosciences Doses First Patients in Phase 2 Clinical Trial of Reversible Thrombolytic BB-031 for Acute Ischemic Stroke businesswire.com/news/home/2024… SHAHID NIMJEE @OSUNeuroInst

Patient dosing has commenced for the phase 2 RAISE study, a pivotal, 2-part trial assessing the safety and preliminary efficacy of BB-031, a first-in-class RNA aptamer targeting von Willebrand Factor in patients with #AIS. SHAHID NIMJEE The Ohio State University Wexner Medical Center neurologylive.com/view/patient-d…

Phase 2 trial underway to test vWF inhibition in AIS patients. Ohio State Neurosurgery Residency

Here is SHAHID NIMJEE, one of OSU’s dual trained vascular experts, giving a talk at the OHSNS annual meeting on the endovascular treatment of aneurysms.

Next generation pharmaceutical technologies @deepwelldtx will be led by Russell Lonser, M.D.: nam12.safelinks.protection.outlook.com/?url=https%3A%…

Rerupture of an Aneurysmal Subarachnoid Hemorrhage | New England Journal of Medicine nejm.org/doi/full/10.10…

Thank you to SHAHID NIMJEE, one of our dual trained open/endovascular experts, for the great Grand Rounds talk on mechanical thrombectomy for LVO stroke! 🧠

🤔 How much do you know about #thrombosis? On #WorldThrombosisDay, learn about blood clots (thrombus) within blood vessels that obstruct blood flow and lead to acute ischemic stroke, as well as Basking's approach to address #AIS. baskingbiosciences.com/pipeline/

Honored to have Dr. Adnan Qureshi and Dr Shahid Nimjee join us in Toledo for the Annual Stroke Update Conference … we had an excellent turnout and amazing talks … good times and memories! Mouhammad Jumaa SHAHID NIMJEE

⏰ Stroke can’t wait. Neither should we. I’m proud to be working with our Basking Biosciences team to develop innovative treatments that extend the critical time window and expand access for stroke patients. #WorldStrokeDay2024

Newly published research reports the superior efficacy and safety of novel RNA aptamer BB-031, compared to the standard treatment with rTPA in a canine model of basilar artery occlusion. frontiersin.org/journals/neuro…. Ohio State Neurosurgery Residency The Ohio State Department of Neuroscience

Incredible start to 2025! Thrilled to join such a talented, passionate team for brainstorming, planning, and celebrating our shared mission. Here’s to a transformative year ahead!

Great discussion with C. Michael Gibson MD about von Willebrand Factor’s role in blood clot formation and contraction and its potential as a target for ischemic stroke treatment. Excited to be advancing our novel thrombolytic BB-031 through Ph 2 in the clinic!  bit.ly/40l2VJ8

Just returned from the International Stroke Conference with another jolt of data about who to treat for #stroke! Always great to see and spend time with friends!! Stavropoula Tjoumakaris MD, MBA, FAANS, FACS, FAHA Shazam Hussain, MD Tudor G. Jovin, MD Ameer E. Hassan Brett Wall Jens Fiehler Nima Etminan SHAHID NIMJEE

🧠⚡Stroke is a leading cause of death and disability—but early action saves lives. This #StrokeAwarenessMonth, know the signs (FAST) and share them. Let’s be faster than stroke. 🔗 stroke.org/en/about-strok…

Thanks to the Solas BioVentures team for the invite! Grateful for the chance to connect and have great conversations around even greater science! Dave adair Solas BioVentures

🧠⚡Stroke is treatable—and we’re developing the next chapter in care. Learn how BB-031 could shift the paradigm of ischemic stroke treatment: baskingbiosciences.com/#StrokeAwarene…  #AHAstrokemonth

Great to see the Basking team in action at #ESOC2025. Energizing to connect with our global investigators and longtime advisors—all pushing stroke research forward. Big thanks to all who joined us in Helsinki! 👋 #StrokeResearch #ClinicalTrials #GlobalCollaboration